These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3997577)

  • 41. Evaluation of bioactive glass for mastoid obliteration: a guinea pig model.
    Jang CH; Cho YB; Bae CS
    In Vivo; 2007; 21(4):651-5. PubMed ID: 17708361
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Apatite ceramic as a reconstruction material for the posterior wall of the external auditory meatus].
    Nishiyama S
    Nihon Jibiinkoka Gakkai Kaiho; 1987 Feb; 90(2):159-67. PubMed ID: 3598761
    [No Abstract]   [Full Text] [Related]  

  • 43. Application of modified transmastoid approach methods to congenital atresia of the external ear canal with middle ear infection.
    Yamane H; Sunami K; Takayama M; Tochino R; Konishi K; Iguchi H; Sakashita T; Kusuki M
    Acta Otolaryngol Suppl; 2004 Oct; (554):38-44. PubMed ID: 15513509
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Labyrinthine fistula: an unreported complication of the Grote prosthesis.
    Gadre AK; Hammerschlag PE
    Laryngoscope; 2001 May; 111(5):796-800. PubMed ID: 11359158
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Canal atresia: "surgery or implantable hearing devices? The expert's question is revisited".
    Evans AK; Kazahaya K
    Int J Pediatr Otorhinolaryngol; 2007 Mar; 71(3):367-74. PubMed ID: 17196671
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ceravital versus plastipore in tympanoplasty: a randomized prospective trial.
    Mangham CA; Lindeman RC
    Ann Otol Rhinol Laryngol; 1990 Feb; 99(2 Pt 1):112-6. PubMed ID: 2301864
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Alloplastic materials in otological surgery. An update].
    Bernal Sprekelsen M; Marco Algarra J
    An Otorrinolaringol Ibero Am; 1992; 19(3):225-42. PubMed ID: 1616071
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reconstruction of defects in the anterior skull base with calcium phosphate ceramics.
    Mattelin W; Albers FW
    Acta Otorhinolaryngol Belg; 1993; 47(3):335-8. PubMed ID: 8213144
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A randomized, blinded study of canal wall up versus canal wall down mastoidectomy determining the differences in viewing middle ear anatomy and pathology.
    Hulka GF; McElveen JT
    Am J Otol; 1998 Sep; 19(5):574-8. PubMed ID: 9752963
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [An experimental study of bioactive glass ceramics as orbital implants].
    Xu X; Wang C; Huang T; Ding L; Huang Z; Zhang X
    Hunan Yi Ke Da Xue Xue Bao; 1997; 22(1):25-8. PubMed ID: 9868022
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Our experience with ossicular prostheses of Ceravital].
    Gersdorff M
    Rev Laryngol Otol Rhinol (Bord); 1985; 106(5):329-34. PubMed ID: 3834549
    [No Abstract]   [Full Text] [Related]  

  • 52. [Histological study of the binding of Polycel and Ceravital implants to the stapes footplate in rabbits].
    Schmid S; Felix H; Böhmer A
    HNO; 1988 Jun; 36(6):221-5. PubMed ID: 3410757
    [TBL] [Abstract][Full Text] [Related]  

  • 53. SerenoCem -glass ionomeric granules: a 3-year follow-up assessment of their effectiveness in mastoid obliteration.
    Clark MP; Bottrill I
    Clin Otolaryngol; 2007 Aug; 32(4):287-90. PubMed ID: 17651273
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Ceramic implants in middle ear surgery (author's transl)].
    Jahnke K; Plester D
    HNO; 1980 Apr; 28(4):109-14. PubMed ID: 7451257
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Tooth roots made of Ceravital. 1 year's clinical results with a bioactive implantation material].
    Strunz V; Bunte M; Sauer G
    Dtsch Zahnarztl Z; 1977 Nov; 32(11):903-4. PubMed ID: 270402
    [No Abstract]   [Full Text] [Related]  

  • 56. Preliminary experience with beta-tricalcium phosphate for use in mastoid cavity obliteration after mastoidectomy.
    Minoda R; Hayashida M; Masuda M; Yumoto E
    Otol Neurotol; 2007 Dec; 28(8):1018-21. PubMed ID: 17898672
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reversible canal wall down mastoidectomy for acquired cholesteatomas: preliminary results.
    McElveen JT; Chung AT
    Laryngoscope; 2003 Jun; 113(6):1027-33. PubMed ID: 12782816
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Clinical experiences with the application of individualized alveolar packing using a bioactive ceramic glass].
    Breustedt A; Schubert R; Berger G
    Protet Stomatol; 1983; 33(3):175-7. PubMed ID: 6585863
    [No Abstract]   [Full Text] [Related]  

  • 59. [New ceramic implants for reconstruction of the ear ossicle chain].
    Jahnke K
    Laryngorhinootologie; 1992 Jan; 71(1):1-4. PubMed ID: 1543514
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Clinical use of BAS-O, a bioactive glass ceramic, for filling cystic cavities in stomatology].
    Pávek V; Novák Z; Strnad Z; Kudrnová D; Navrátilová B
    Sb Lek; 1993; 94(3):239-48. PubMed ID: 7973419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.